Skip to main content

Peer Review reports

From: Trial design and rationale for APOLLO, a Phase 3, placebo-controlled study of patisiran in patients with hereditary ATTR amyloidosis with polyneuropathy

Original Submission
4 Apr 2017 Submitted Original manuscript
9 Jun 2017 Reviewed Reviewer Report - Davide Pareyson
30 Jun 2017 Reviewed Reviewer Report - Laura Obici
2 Aug 2017 Author responded Author comments - David Adams
Resubmission - Version 2
2 Aug 2017 Submitted Manuscript version 2
21 Aug 2017 Author responded Author comments - David Adams
Resubmission - Version 3
21 Aug 2017 Submitted Manuscript version 3
Publishing
22 Aug 2017 Editorially accepted
11 Sep 2017 Article published 10.1186/s12883-017-0948-5

You can find further information about peer review here.

Back to article page